Ausgabe 10/2013
Inhalt (10 Artikel)
Late divergence of survival curves in cancer immunotherapy trials: interpretation and implications
Fredrik B. Thorén, Harald Anderson, Örjan Strannegård
Dendritic cell phenotype can be improved by certain chemotherapies and is associated with alterations to p21waf1/cip1
Wai Man Liu, Katherine Ann Scott, Mareike Thompson, Angus George Dalgleish
Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients
Anna Casati, Azam Varghaei-Nahvi, Steven Alexander Feldman, Mario Assenmacher, Steven Aaron Rosenberg, Mark Edward Dudley, Alexander Scheffold
Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma
Bo Wang, Lian Li, Yuan Liao, Jinqing Li, Xingjuan Yu, Yi Zhang, Jing Xu, Huilan Rao, Shupeng Chen, Lanjun Zhang, Limin Zheng
Empty liposomes induce antitumoral effects associated with macrophage responses distinct from those of the TLR1/2 agonist Pam3CSK4 (BLP)
Simone König, Tommy Regen, Kai Dittmann, Michael Engelke, Jürgen Wienands, Reto Schwendener, Uwe-Karsten Hanisch, Tobias Pukrop, Heidi Hahn
AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial
Sonia A. Perez, Eleftheria A. Anastasopoulou, Panagiotis Tzonis, Cécile Gouttefangeas, Hubert Kalbacher, Michail Papamichail, Constantin N. Baxevanis
Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis
Monireh Mohsenzadegan, Zahra Madjd, Mojgan Asgari, Maryam Abolhasani, Mehdi Shekarabi, Jaleh Taeb, Ahmad Shariftabrizi
DEAD/H (Asp–Glu–Ala–Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells
Jun Koshio, Hiroshi Kagamu, Koichiro Nozaki, Yu Saida, Tomohiro Tanaka, Satoshi Shoji, Natsue Igarashi, Satoru Miura, Masaaki Okajima, Satoshi Watanabe, Hirohisa Yoshizawa, Ichiei Narita
Efficacy of postoperative adjuvant transfusion of cytokine-induced killer cells combined with chemotherapy in patients with colorectal cancer
Yanjuan Zhu, Haibo Zhang, Yong Li, Jianping Bai, Lirong Liu, Yihong Liu, Yanchun Qu, Xin Qu
Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1
Yibing Xu, Jianping Sun, Michael A. Sheard, Hung C. Tran, Zesheng Wan, Wei Yao Liu, Shahab Asgharzadeh, Richard Sposto, Hong Wei Wu, Robert C. Seeger